CPT 17000 - Destruction, premalignant lesion, first
Medicare documentation, audit risk, and billing facts.
CPT 17000 represents the primary code for the destruction of premalignant lesions, most commonly actinic keratoses. This procedure is classified as a minor surgical service and carries a 10 day global period. For small practices, the primary challenge lies in understanding that the global package includes the pre - operative assessment, local anesthesia, the actual destruction, and routine follow - up care. A common misconception is that the initial evaluation of the lesion on the same day always warrants a separate Evaluation and Management (E/M) code. However, Medicare guidelines state that the work associated with the decision to perform a minor procedure is included in the surgical payment unless the E/M service is significant and separately identifiable.
Applying Modifier 25 to an E/M code billed with 17000 is a high - frequency audit target. To survive a contractor review, the medical record must clearly differentiate the work of the E/M from the work of the procedure. For example, if a patient presents for a comprehensive skin examination and the physician discovers an actinic keratosis to treat, the E/M may be justified if the documentation supports a full - body review. Conversely, if the patient presents specifically for the treatment of a known lesion, a separate E/M is generally not allowed and will be flagged as a bundled service.
Small practices also face risks regarding lesion counts and the use of add - on codes like 17003. Unlike 17000, which covers the first lesion, auditors look for specific anatomic site mapping and individual lesion counts in the operative note to justify multiple units. Documentation that simply states "multiple lesions treated" without specifying the count or locations will likely lead to denials or recoupment during an audit. Practices must ensure their templates force the capture of these specific data points to remain compliant with NCD 250.4 requirements. The absence of a detailed lesion map is often the first red flag for Medicare recovery audit contractors.
Audit traps
- Unjustified Modifier 25Billing an E/M for the evaluation of the same lesion treated during the encounter without documenting a separate medical necessity beyond the procedure decision.
- Vague Lesion CountsFailing to document the exact number and anatomic locations of lesions treated, which is required to support CPT 17000 and subsequent add - on units.
- Global Period ViolationsBilling for routine post - operative wound checks or follow - up visits within the 10 day global period following the destruction service.
- Incomplete Diagnosis DocumentationFailing to specifically identify the lesions as actinic keratoses or premalignant, which is a core requirement for coverage under NCD 250.4.
Improper modifier usage is the #1 reason CPT 17000 gets audited. d3rx's Compliance Binder ensures your documentation meets NCD 250.4 standards for every lesion. -> /compliance-binder
Build your Compliance Binder →Comparisons
FAQ
- What is the global period for CPT 17000?
- CPT 17000 is a minor procedure that typically has a 10 day global period, meaning routine follow - up care and the initial assessment are included in the payment.
- Can I bill an office visit and CPT 17000 on the same day?
- Only if the office visit is for a significant and separately identifiable reason, which must be supported by documentation and indicated with Modifier 25.
- What documentation is required for actinic keratosis destruction?
- The record must identify the diagnosis, the exact count of lesions, their anatomic sites, the treatment method used, and the medical necessity for the procedure.
- Is cryosurgery the only covered method for 17000?
- No, NCD 250.4 also lists topical drug therapy, curettage, and other surgical methods as covered options for the destruction of actinic keratoses.
- When should Modifier 59 be used with 17000?
- Modifier 59 is used to identify a distinct procedural service performed on the same day, such as treating a separate lesion at a different site using a different method.